摘要
背景:线粒体乌头酸酶(Aco2)是含铁硫[4Fe-4S]的脱水酶家族的成员,通过三羧酸循环参与细胞代谢。 Aco2非常容易受到氧化损伤,因为暴露于活性物质和自由基会导致中心[4Fe-4S]簇中的铁释放,从而导致产生无活性形式的Aco2。 目的:越来越多的证据支持神经细胞中能量代谢受损与神经退行性疾病发生和发展之间的直接关联。 结果:已经表明生物能参数的改变是导致神经元功能障碍的神经退行性疾病的常见病理学特征。许多研究表明,功能失调的Aco2在其他生物能量参数中是促进神经变性的关键因素。 结论:增加我们关于能量代谢相关分子(包括受神经退行性疾病影响的Aco2)的知识可能有助于找到针对这些中枢神经系统相关疾病的有效治疗策略。因此,在这篇综述中,我们重点关注了神经变性中发生的事件和过程,导致大脑中Aco2的失活。
关键词: 线粒体乌头酸酶,神经退行性疾病,氧化应激,铁硫簇,阿尔茨海默氏病。
图形摘要
Current Drug Targets
Title:Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Volume: 19 Issue: 8
关键词: 线粒体乌头酸酶,神经退行性疾病,氧化应激,铁硫簇,阿尔茨海默氏病。
摘要: Background: Mitochondrial aconitase (Aco2), a member of the family of iron-sulfur [4Fe- 4S]-containing dehydratases, is involved in cellular metabolism through the tricarboxylic acid cycle. Aco2 is highly susceptible to oxidative damage in a way that exposure to the reactive species and free radicals leads to release of iron from the central [4Fe-4S] cluster resulting in the production of the inactive form of Aco2.
Objective: There is increasing evidence supporting a direct association between impaired energy metabolism and the incidence and progression of neurodegenerative disorders in neuronal cells.
Results: It has been shown that alteration in bioenergetic parameters is a common pathological feature of the neurodegenerative diseases leading to neuronal dysfunction. Numerous studies have demonstrated that dysfunctional Aco2, among the other bioenergetic parameters, is a key factor that could promote neurodegeneration.
Conclusion: Increasing our knowledge about energy metabolism-related molecules including Aco2 affected by neurodegenerative disorders might be useful to find an efficient therapeutic strategy for those central nervous system-related diseases. Accordingly, in this review, we have focused on the events and processes that occur in neurodegeneration, leading to the inactivation of Aco2 in the brain.
Export Options
About this article
Cite this article as:
Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration, Current Drug Targets 2018; 19 (8) . https://dx.doi.org/10.2174/1389450118666170816124203
DOI https://dx.doi.org/10.2174/1389450118666170816124203 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Current Drug Targets Understanding Gender Differences in Schizophrenia: A Review of the Literature
Current Psychiatry Reviews Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
Current Pharmaceutical Biotechnology Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics
Current Pharmaceutical Design Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Anti-Cancer Agents in Medicinal Chemistry Neurotoxicity: The Broad Framework of Electron Transfer, Oxidative Stress and Protection by Antioxidants
Current Medicinal Chemistry - Central Nervous System Agents Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Autoimmune Neuromuscular Disorders
Current Neuropharmacology Alzheimers Disease and Oxidative Stress: The Old Problem Remains Unsolved
Current Medicinal Chemistry - Central Nervous System Agents Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists
Current Drug Metabolism Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Current Drug Delivery On the Search for Skin Gene Therapy Strategies of Xeroderma Pigmentosum Disease
Current Gene Therapy Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders
Mini-Reviews in Organic Chemistry